| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | 1.09e-06 | 7 | 64 | 3 | GO:0008467 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity | 1.01e-05 | 2 | 64 | 2 | GO:0033872 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 1.39e-05 | 15 | 64 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | fructose-bisphosphate aldolase activity | 3.03e-05 | 3 | 64 | 2 | GO:0004332 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.41e-04 | 614 | 64 | 9 | GO:0140657 | |
| GeneOntologyMolecularFunction | fructose binding | 1.50e-04 | 6 | 64 | 2 | GO:0070061 | |
| GeneOntologyMolecularFunction | aldehyde-lyase activity | 5.46e-04 | 11 | 64 | 2 | GO:0016832 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 7.31e-04 | 55 | 64 | 3 | GO:0008146 | |
| GeneOntologyMolecularFunction | cadherin binding | 7.50e-04 | 339 | 64 | 6 | GO:0045296 | |
| GeneOntologyMolecularFunction | carbon-carbon lyase activity | 7.71e-04 | 56 | 64 | 3 | GO:0016830 | |
| GeneOntologyMolecularFunction | intermediate filament binding | 1.03e-03 | 15 | 64 | 2 | GO:0019215 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.47e-03 | 70 | 64 | 3 | GO:0003777 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 1.73e-03 | 74 | 64 | 3 | GO:0016782 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan metabolic process | 1.88e-05 | 17 | 64 | 3 | GO:0030201 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | ATP7A ACSS1 ABCC5 NME1 HS3ST4 NME2 HS3ST3B1 ALDOA HS3ST3A1 ADCY3 | 8.35e-05 | 736 | 64 | 10 | GO:1901137 |
| GeneOntologyBiologicalProcess | spindle assembly | 1.13e-04 | 153 | 64 | 5 | GO:0051225 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 1.18e-04 | 619 | 64 | 9 | GO:0006163 | |
| GeneOntologyBiologicalProcess | indole-containing compound metabolic process | 1.20e-04 | 31 | 64 | 3 | GO:0042430 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process | 1.74e-04 | 35 | 64 | 3 | GO:0015012 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | 1.74e-04 | 652 | 64 | 9 | GO:0072521 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | ATP7A PLA1A ACSS1 ADGRF5 DGKH OLA1 NME1 NME2 ALDOA ALDOB ADCY3 KMO | 1.77e-04 | 1142 | 64 | 12 | GO:0019637 |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | 1.78e-04 | 512 | 64 | 8 | GO:0009150 | |
| GeneOntologyBiologicalProcess | dTMP biosynthetic process | 1.97e-04 | 7 | 64 | 2 | GO:0006231 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside monophosphate biosynthetic process | 1.97e-04 | 7 | 64 | 2 | GO:0009177 | |
| GeneOntologyBiologicalProcess | purine nucleotide biosynthetic process | 2.30e-04 | 280 | 64 | 6 | GO:0006164 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 2.34e-04 | 533 | 64 | 8 | GO:0009259 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside triphosphate metabolic process | 2.43e-04 | 283 | 64 | 6 | GO:0009205 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 2.48e-04 | 684 | 64 | 9 | GO:0009117 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 2.56e-04 | 540 | 64 | 8 | GO:0019693 | |
| GeneOntologyBiologicalProcess | purine-containing compound biosynthetic process | 2.67e-04 | 288 | 64 | 6 | GO:0072522 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 2.68e-04 | 691 | 64 | 9 | GO:0006753 | |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate metabolic process | 2.77e-04 | 290 | 64 | 6 | GO:0009199 | |
| GeneOntologyBiologicalProcess | purine nucleoside triphosphate metabolic process | 2.83e-04 | 291 | 64 | 6 | GO:0009144 | |
| GeneOntologyBiologicalProcess | fructose 1,6-bisphosphate metabolic process | 3.36e-04 | 9 | 64 | 2 | GO:0030388 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | ATP7A ACSS1 ABCC5 OLA1 NME1 HS3ST4 NME2 HS3ST3B1 ALDOA HS3ST3A1 ALDOB ADCY3 | 3.41e-04 | 1226 | 64 | 12 | GO:1901135 |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | 3.76e-04 | 307 | 64 | 6 | GO:0009141 | |
| GeneOntologyBiologicalProcess | nucleotide biosynthetic process | 4.61e-04 | 319 | 64 | 6 | GO:0009165 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate biosynthetic process | 4.68e-04 | 320 | 64 | 6 | GO:1901293 | |
| GeneOntologyBiologicalProcess | mitotic spindle midzone assembly | 5.12e-04 | 11 | 64 | 2 | GO:0051256 | |
| GeneOntologyBiologicalProcess | UTP biosynthetic process | 5.12e-04 | 11 | 64 | 2 | GO:0006228 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleotide biosynthetic process | 5.12e-04 | 11 | 64 | 2 | GO:0009221 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 5.72e-04 | 767 | 64 | 9 | GO:0055086 | |
| GeneOntologyBiologicalProcess | mitotic spindle elongation | 6.13e-04 | 12 | 64 | 2 | GO:0000022 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, enzymatic modification | 6.13e-04 | 12 | 64 | 2 | GO:0015015 | |
| GeneOntologyBiologicalProcess | deoxyribonucleoside monophosphate biosynthetic process | 6.13e-04 | 12 | 64 | 2 | GO:0009157 | |
| GeneOntologyBiologicalProcess | spindle organization | 6.54e-04 | 224 | 64 | 5 | GO:0007051 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent cytokinesis | 6.55e-04 | 127 | 64 | 4 | GO:0061640 | |
| GeneOntologyBiologicalProcess | GTP biosynthetic process | 7.23e-04 | 13 | 64 | 2 | GO:0006183 | |
| GeneOntologyBiologicalProcess | UTP metabolic process | 7.23e-04 | 13 | 64 | 2 | GO:0046051 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide biosynthetic process | 7.66e-04 | 232 | 64 | 5 | GO:0009152 | |
| GeneOntologyBiologicalProcess | organophosphate biosynthetic process | 8.20e-04 | 644 | 64 | 8 | GO:0090407 | |
| GeneOntologyBiologicalProcess | spindle midzone assembly | 8.42e-04 | 14 | 64 | 2 | GO:0051255 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 8.42e-04 | 14 | 64 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | spindle elongation | 8.42e-04 | 14 | 64 | 2 | GO:0051231 | |
| GeneOntologyBiologicalProcess | dTMP metabolic process | 8.42e-04 | 14 | 64 | 2 | GO:0046073 | |
| GeneOntologyBiologicalProcess | tryptophan metabolic process | 8.42e-04 | 14 | 64 | 2 | GO:0006568 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | FLNA ABCA1 ATP7A AHNAK CDKL3 FNIP1 CCT4 CUL7 NME1 NME2 MEX3B MPP7 | 8.94e-04 | 1366 | 64 | 12 | GO:0051130 |
| GeneOntologyBiologicalProcess | CTP biosynthetic process | 9.70e-04 | 15 | 64 | 2 | GO:0006241 | |
| GeneOntologyBiologicalProcess | ribonucleotide biosynthetic process | 1.01e-03 | 247 | 64 | 5 | GO:0009260 | |
| GeneOntologyBiologicalProcess | pyrimidine ribonucleoside triphosphate biosynthetic process | 1.11e-03 | 16 | 64 | 2 | GO:0009209 | |
| GeneOntologyBiologicalProcess | fructose metabolic process | 1.11e-03 | 16 | 64 | 2 | GO:0006000 | |
| GeneOntologyBiologicalProcess | indolalkylamine metabolic process | 1.11e-03 | 16 | 64 | 2 | GO:0006586 | |
| GeneOntologyBiologicalProcess | ribose phosphate biosynthetic process | 1.13e-03 | 253 | 64 | 5 | GO:0046390 | |
| GeneOntologyBiologicalProcess | CTP metabolic process | 1.25e-03 | 17 | 64 | 2 | GO:0046036 | |
| GeneOntologyBiologicalProcess | pyrimidine deoxyribonucleoside monophosphate metabolic process | 1.25e-03 | 17 | 64 | 2 | GO:0009176 | |
| GeneOntologyBiologicalProcess | proteoglycan biosynthetic process | 1.34e-03 | 70 | 64 | 3 | GO:0030166 | |
| HumanPheno | Reduced circulating aldolase concentration | 1.32e-05 | 2 | 19 | 2 | HP:0012545 | |
| MousePheno | small hippocampus | 1.95e-05 | 46 | 49 | 4 | MP:0008283 | |
| MousePheno | increased dendritic spine number | 3.60e-05 | 3 | 49 | 2 | MP:0021019 | |
| MousePheno | abnormal hippocampus size | 3.98e-05 | 55 | 49 | 4 | MP:0008281 | |
| MousePheno | premature acrosome reaction | 7.19e-05 | 4 | 49 | 2 | MP:0013288 | |
| MousePheno | increased thigmotaxis | 9.51e-05 | 132 | 49 | 5 | MP:0002797 | |
| MousePheno | decreased interleukin-12 secretion | 1.39e-04 | 29 | 49 | 3 | MP:0008664 | |
| Domain | KH_1 | 8.48e-06 | 38 | 64 | 4 | PF00013 | |
| Domain | - | 9.42e-06 | 39 | 64 | 4 | 3.30.1370.10 | |
| Domain | KH | 1.04e-05 | 40 | 64 | 4 | SM00322 | |
| Domain | KH_dom | 1.04e-05 | 40 | 64 | 4 | IPR004087 | |
| Domain | KH_TYPE_1 | 1.27e-05 | 42 | 64 | 4 | PS50084 | |
| Domain | KH_dom_type_1 | 1.54e-05 | 44 | 64 | 4 | IPR004088 | |
| Domain | P-loop_NTPase | ABCA1 STARD9 EIF2S3 SEPTIN1 KIF4A ABCC5 KIF4B OLA1 HS3ST4 HS3ST3B1 HS3ST3A1 MPP7 | 2.64e-05 | 848 | 64 | 12 | IPR027417 |
| Domain | FBA_I | 3.46e-05 | 3 | 64 | 2 | IPR000741 | |
| Domain | Glycolytic | 3.46e-05 | 3 | 64 | 2 | PF00274 | |
| Domain | Aldolase_I_AS | 3.46e-05 | 3 | 64 | 2 | IPR029768 | |
| Domain | ALDOLASE_CLASS_I | 3.46e-05 | 3 | 64 | 2 | PS00158 | |
| Domain | Nucleoside_diP_kinase_AS | 1.15e-04 | 5 | 64 | 2 | IPR023005 | |
| Domain | Sulfotransferase_dom | 2.53e-04 | 36 | 64 | 3 | IPR000863 | |
| Domain | Sulfotransfer_1 | 2.53e-04 | 36 | 64 | 3 | PF00685 | |
| Domain | Kinesin_motor_CS | 3.73e-04 | 41 | 64 | 3 | IPR019821 | |
| Domain | NDP_KINASES | 4.10e-04 | 9 | 64 | 2 | PS00469 | |
| Domain | KINESIN_MOTOR_1 | 4.60e-04 | 44 | 64 | 3 | PS00411 | |
| Domain | - | 4.60e-04 | 44 | 64 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 4.60e-04 | 44 | 64 | 3 | IPR001752 | |
| Domain | Kinesin | 4.60e-04 | 44 | 64 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 4.60e-04 | 44 | 64 | 3 | PS50067 | |
| Domain | KISc | 4.60e-04 | 44 | 64 | 3 | SM00129 | |
| Domain | NDK | 5.11e-04 | 10 | 64 | 2 | SM00562 | |
| Domain | IG_FLMN | 5.11e-04 | 10 | 64 | 2 | SM00557 | |
| Domain | NDK | 5.11e-04 | 10 | 64 | 2 | PF00334 | |
| Domain | Filamin | 6.23e-04 | 11 | 64 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 6.23e-04 | 11 | 64 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 6.23e-04 | 11 | 64 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 6.23e-04 | 11 | 64 | 2 | IPR017868 | |
| Domain | Nucleoside_diP_kinase | 7.46e-04 | 12 | 64 | 2 | IPR001564 | |
| Domain | - | ABCA1 EIF2S3 SEPTIN1 ABCC5 OLA1 HS3ST4 HS3ST3B1 HS3ST3A1 MPP7 | 9.49e-04 | 746 | 64 | 9 | 3.40.50.300 |
| Domain | Actinin_actin-bd_CS | 2.79e-03 | 23 | 64 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 2.79e-03 | 23 | 64 | 2 | PS00020 | |
| Domain | ACTININ_1 | 2.79e-03 | 23 | 64 | 2 | PS00019 | |
| Domain | ZF_RING_1 | 3.20e-03 | 291 | 64 | 5 | PS00518 | |
| Domain | ZF_RING_2 | 3.54e-03 | 298 | 64 | 5 | PS50089 | |
| Domain | RING | 3.90e-03 | 305 | 64 | 5 | SM00184 | |
| Domain | Znf_RING | 5.17e-03 | 326 | 64 | 5 | IPR001841 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 6.66e-05 | 23 | 49 | 3 | M45013 | |
| Pathway | REACTOME_AZATHIOPRINE_ADME | 1.09e-04 | 27 | 49 | 3 | MM15693 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 1.35e-04 | 29 | 49 | 3 | MM14802 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 1.66e-04 | 31 | 49 | 3 | M685 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.34e-04 | 271 | 49 | 6 | MM15406 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 4.61e-04 | 288 | 49 | 6 | M16864 | |
| Pathway | REACTOME_RIBAVIRIN_ADME | 6.38e-04 | 11 | 49 | 2 | M46429 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 6.38e-04 | 11 | 49 | 2 | M48099 | |
| Pathway | REACTOME_RIBAVIRIN_ADME | 7.64e-04 | 12 | 49 | 2 | MM16638 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 8.63e-04 | 123 | 49 | 4 | MM14623 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 8.64e-04 | 54 | 49 | 3 | MM14633 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 9.45e-04 | 126 | 49 | 4 | M695 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.01e-03 | 57 | 49 | 3 | M692 | |
| Pathway | BIOCARTA_NDKDYNAMIN_PATHWAY | 1.21e-03 | 15 | 49 | 2 | MM1387 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 1.29e-03 | 62 | 49 | 3 | M11521 | |
| Pubmed | 1.56e-10 | 6 | 64 | 4 | 17267406 | ||
| Pubmed | 5.10e-09 | 12 | 64 | 4 | 18779327 | ||
| Pubmed | Cell cycle-dependent palmitoylation of protocadherin 7 by ZDHHC5 promotes successful cytokinesis. | 1.82e-08 | 159 | 64 | 7 | 36762613 | |
| Pubmed | 2.19e-08 | 94 | 64 | 6 | 35122331 | ||
| Pubmed | CDX2 regulation by the RNA-binding protein MEX3A: impact on intestinal differentiation and stemness. | 2.37e-08 | 4 | 64 | 3 | 23408853 | |
| Pubmed | 3.68e-07 | 247 | 64 | 7 | 30713523 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.08e-06 | 203 | 64 | 6 | 22083510 | |
| Pubmed | 2.54e-06 | 330 | 64 | 7 | 32529326 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 2.67e-06 | 477 | 64 | 8 | 31300519 | |
| Pubmed | 3.27e-06 | 16 | 64 | 3 | 9988767 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 3.33e-06 | 2 | 64 | 2 | 36482480 | |
| Pubmed | Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development. | 3.33e-06 | 2 | 64 | 2 | 2509941 | |
| Pubmed | Whole genome expression microarray reveals novel roles for Kif4 in monocyte/macrophage cells. | 3.33e-06 | 2 | 64 | 2 | 31486502 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 16192292 | ||
| Pubmed | A novel Arabidopsis gene causes Bax-like lethality in Saccharomyces cerevisiae. | 3.33e-06 | 2 | 64 | 2 | 16192270 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 10773663 | ||
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 3.33e-06 | 2 | 64 | 2 | 30081192 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 31616463 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12200143 | ||
| Pubmed | Chromokinesin Kif4 promotes proper anaphase in mouse oocyte meiosis. | 3.33e-06 | 2 | 64 | 2 | 31067151 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 28350061 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21085602 | ||
| Pubmed | A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. | 3.33e-06 | 2 | 64 | 2 | 10520990 | |
| Pubmed | Long-chain fatty acyl coenzyme A inhibits NME1/2 and regulates cancer metastasis. | 3.33e-06 | 2 | 64 | 2 | 35259022 | |
| Pubmed | Aldolase-B knockout in mice phenocopies hereditary fructose intolerance in humans. | 3.33e-06 | 2 | 64 | 2 | 25637246 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 8245015 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12007505 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 15304505 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 12972261 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22475533 | ||
| Pubmed | Cellular motor protein KIF-4 associates with retroviral Gag. | 3.33e-06 | 2 | 64 | 2 | 10559369 | |
| Pubmed | Kif4 interacts with EB1 and stabilizes microtubules downstream of Rho-mDia in migrating fibroblasts. | 3.33e-06 | 2 | 64 | 2 | 24658398 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21565503 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 7689010 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 7929562 | ||
| Pubmed | Structural basis for the ATP-induced isomerization of kinesin. | 3.33e-06 | 2 | 64 | 2 | 23500491 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 10679933 | ||
| Pubmed | The Potential Functional Roles of NME1 Histidine Kinase Activity in Neuroblastoma Pathogenesis. | 3.33e-06 | 2 | 64 | 2 | 32392889 | |
| Pubmed | Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein. | 3.33e-06 | 2 | 64 | 2 | 9658142 | |
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 3.33e-06 | 2 | 64 | 2 | 24469451 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 4.26e-06 | 357 | 64 | 7 | 37059091 | |
| Pubmed | 5.03e-06 | 61 | 64 | 4 | 20548051 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNA FLNC EIF2S3 RBM10 AHNAK RPS7 CCT4 NME1 NME2 ALDOA COPS6 | 7.29e-06 | 1149 | 64 | 11 | 35446349 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 7.58e-06 | 934 | 64 | 10 | 33916271 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 7.87e-06 | 256 | 64 | 6 | 33397691 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 8.40e-06 | 558 | 64 | 8 | 27591049 | |
| Pubmed | 8.50e-06 | 397 | 64 | 7 | 21319273 | ||
| Pubmed | 9.54e-06 | 153 | 64 | 5 | 27462432 | ||
| Pubmed | Mode of interactions of human aldolase isozymes with cytoskeletons. | 9.99e-06 | 3 | 64 | 2 | 9244396 | |
| Pubmed | Aldolase positively regulates of the canonical Wnt signaling pathway. | 9.99e-06 | 3 | 64 | 2 | 24993527 | |
| Pubmed | Nm23/NDP kinases in human male germ cells: role in spermiogenesis and sperm motility? | 9.99e-06 | 3 | 64 | 2 | 14499630 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11252955 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 12704190 | ||
| Pubmed | ABC transporters as differentiation markers in glioblastoma cells. | 9.99e-06 | 3 | 64 | 2 | 25028266 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19805292 | ||
| Pubmed | Association of nucleoside diphosphate kinase nm23-H2 with human telomeres. | 9.99e-06 | 3 | 64 | 2 | 9480811 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 30411342 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 15530864 | ||
| Pubmed | Substrate specificity of human nucleoside-diphosphate kinase revealed by transient kinetic analysis. | 9.99e-06 | 3 | 64 | 2 | 9488696 | |
| Pubmed | Assignment of a locus for autosomal dominant idiopathic scoliosis (IS) to human chromosome 17p11. | 9.99e-06 | 3 | 64 | 2 | 12384783 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11277919 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 8543593 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11038172 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 19619546 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 9881672 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 16890532 | ||
| Pubmed | KIF4 mediates anterograde translocation and positioning of ribosomal constituents to axons. | 9.99e-06 | 3 | 64 | 2 | 19158085 | |
| Pubmed | Organization and expression of mouse nm23-M1 gene. Comparison with nm23-M2 expression. | 9.99e-06 | 3 | 64 | 2 | 10452942 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 32860079 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 8270257 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 25748386 | ||
| Pubmed | Identification of the human homologue of mouse KIF4, a kinesin superfamily motor protein. | 9.99e-06 | 3 | 64 | 2 | 10978527 | |
| Pubmed | Novel roles of NM23 proteins in skin homeostasis, repair and disease. | 9.99e-06 | 3 | 64 | 2 | 16862176 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11102480 | ||
| Pubmed | Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis. | 9.99e-06 | 3 | 64 | 2 | 11042679 | |
| Pubmed | KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. | 9.99e-06 | 3 | 64 | 2 | 16630823 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 33024267 | ||
| Pubmed | Filamin A negatively regulates the transcriptional activity of p73alpha in the cytoplasm. | 9.99e-06 | 3 | 64 | 2 | 17825253 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 8392752 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 6696436 | ||
| Pubmed | Disrupted IRF6-NME1/2 Complexes as a Cause of Cleft Lip/Palate. | 9.99e-06 | 3 | 64 | 2 | 28767310 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 22080566 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 12393796 | ||
| Pubmed | nm23 regulates decidualization through the PI3K-Akt-mTOR signaling pathways in mice and humans. | 9.99e-06 | 3 | 64 | 2 | 27604954 | |
| Pubmed | Increased lung metastasis in transgenic NM23-Null/SV40 mice with hepatocellular carcinoma. | 9.99e-06 | 3 | 64 | 2 | 15928304 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 1851158 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 25010650 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 35579738 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 9412467 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 22421058 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 11153914 | ||
| Pubmed | NM23 proteins: innocent bystanders or local energy boosters for CFTR? | 9.99e-06 | 3 | 64 | 2 | 29251738 | |
| Pubmed | The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. | 9.99e-06 | 3 | 64 | 2 | 11960382 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 8600152 | ||
| Pubmed | 1.06e-05 | 411 | 64 | 7 | 36652389 | ||
| Pubmed | 1.09e-05 | 271 | 64 | 6 | 26816005 | ||
| Pubmed | 1.22e-05 | 777 | 64 | 9 | 35844135 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 1.64e-05 | 807 | 64 | 9 | 30575818 | |
| Pubmed | Novel interactors and a role for supervillin in early cytokinesis. | 1.88e-05 | 28 | 64 | 3 | 20309963 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 1.92e-05 | 626 | 64 | 8 | 33644029 | |
| Interaction | PRPF8 interactions | FLNA ABCA1 MEX3A EIF2S3 AHNAK RPS7 CCT4 CUL7 NME1 ALDOA MEX3B MEX3C | 5.08e-06 | 776 | 64 | 12 | int:PRPF8 |
| Interaction | PER2 interactions | 9.05e-06 | 153 | 64 | 6 | int:PER2 | |
| Interaction | LGALS9 interactions | 1.52e-05 | 588 | 64 | 10 | int:LGALS9 | |
| Interaction | FLCN interactions | 1.64e-05 | 100 | 64 | 5 | int:FLCN | |
| Interaction | PCDH7 interactions | 2.86e-05 | 279 | 64 | 7 | int:PCDH7 | |
| Interaction | COL7A1 interactions | 6.68e-05 | 25 | 64 | 3 | int:COL7A1 | |
| Cytoband | 17q21.3 | 2.27e-04 | 16 | 64 | 2 | 17q21.3 | |
| Cytoband | 17p12 | 2.16e-03 | 49 | 64 | 2 | 17p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p12 | 3.65e-03 | 64 | 64 | 2 | chr17p12 | |
| GeneFamily | Sulfotransferases, membrane bound | 1.72e-04 | 37 | 53 | 3 | 763 | |
| GeneFamily | NME/NM23 family | 3.00e-04 | 9 | 53 | 2 | 961 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 3.30e-04 | 46 | 53 | 3 | 622 | |
| GeneFamily | Ring finger proteins | 1.24e-03 | 275 | 53 | 5 | 58 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.10e-03 | 206 | 53 | 4 | 682 | |
| Coexpression | GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP | 8.97e-06 | 198 | 64 | 6 | M4096 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.10e-05 | 97 | 64 | 5 | gudmap_developingGonad_e18.5_epididymis_1000_k4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.88e-06 | 164 | 64 | 5 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.16e-06 | 186 | 64 | 5 | 41e03be964044dae690d566bd078dab3d8045eba | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.35e-06 | 187 | 64 | 5 | 2b1b2c3792d6c9ab69675ce88842bb589414b530 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 9.00e-06 | 195 | 64 | 5 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | CV-Moderate-5|Moderate / Virus stimulation, Condition and Cluster | 9.00e-06 | 195 | 64 | 5 | 646d06ac3fa20acb172735c88cf45e01d212cebf | |
| ToppCell | CV-Moderate-5|CV / Virus stimulation, Condition and Cluster | 9.00e-06 | 195 | 64 | 5 | 7a0bb304c659dd108b75d0c5d19eca5e63cf856d | |
| ToppCell | COVID-19-Myeloid-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 9.23e-06 | 196 | 64 | 5 | 4929cfed1f150c1fde4d79cb49895c2ea467a18f | |
| ToppCell | 10x5'v1-week_12-13|World / cell types per 3 fetal stages;per 3',per 5' | 9.46e-06 | 197 | 64 | 5 | 4b107359f2d703a1d0348932a6b64eb447d30b3d | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-06 | 198 | 64 | 5 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | Macroglial-Astrocytes-GFAP---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.02e-05 | 200 | 64 | 5 | 88d66550781a3c9102ff7455f5cff6fb072943cd | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-05 | 200 | 64 | 5 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | Macroglial-Astrocytes-GFAP-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.02e-05 | 200 | 64 | 5 | d6a059b0ef763c281c60b1ac76da6079ea822f80 | |
| ToppCell | Macroglial-Astrocytes-GFAP--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.02e-05 | 200 | 64 | 5 | 16269fa4adb28fc6ed032bbdba8781237dd0d249 | |
| ToppCell | Macroglial-Astrocytes-GFAP----L1-2|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.02e-05 | 200 | 64 | 5 | c6f43bbbd5df5f2c19ae385f1a6b6a330abede2f | |
| ToppCell | Macroglial-Astrocytes-GFAP|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.02e-05 | 200 | 64 | 5 | 79634b1086934412ae92f259ab43554ce545008f | |
| ToppCell | control-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.17e-05 | 125 | 64 | 4 | 30f593fadbe850cedd622711005f9069ad57cc03 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 144 | 64 | 4 | bf26a7f9eefa229ef489b66fd74cebbd4720da6c | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-05 | 153 | 64 | 4 | 39ac25c48e73538f1c10f37bea386e0e88d3e8d0 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.12e-05 | 164 | 64 | 4 | 6a41a159134e605b80d5e731f9ed5bc803bb531b | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.12e-05 | 164 | 64 | 4 | ec68954fc09b6850273b5e59caa6b09d02151097 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_Tcm|Control / Disease, condition lineage and cell class | 9.34e-05 | 165 | 64 | 4 | c55f91c4dc70d5021b4efcc795024eb1681d2564 | |
| ToppCell | Ionocyte|World / shred by cell class for turbinate | 9.34e-05 | 165 | 64 | 4 | 0cb2199b87f17ece743fb2652b2f448dfa78ae0b | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.56e-05 | 166 | 64 | 4 | 27af6c906cff1d40d134f0386db7708869691121 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 168 | 64 | 4 | 04a7810f95196a21325356b42084f96c11af5964 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 172 | 64 | 4 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-04 | 172 | 64 | 4 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-04 | 174 | 64 | 4 | 5f4436863a40f8bca46e2989bca66c02b6be88d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 175 | 64 | 4 | 77c16e615c0fb9c83f29d7e0a547be72635fac81 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 175 | 64 | 4 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | droplet-Kidney-nan-21m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 176 | 64 | 4 | 0475db3f860de1e216cbdeb886f7a75b9f4fc801 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_Tem|Control / Disease, condition lineage and cell class | 1.22e-04 | 177 | 64 | 4 | 3fba0c5edf816ce7f3c2af424f46c83477528878 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.22e-04 | 177 | 64 | 4 | 191c14e0ef162536028b841f3759aaddef59b49d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | ea2c2d2d7ffd34780882299229ff8614fdd7c79c | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 177 | 64 | 4 | 63b5ebbe505f22091bc7b0db818e01fae5d92bb7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.25e-04 | 178 | 64 | 4 | 4813d6509738f088c12ebf395b70d496af04649a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 179 | 64 | 4 | 025d414ec88d5680d99c8173e70ee3bb0b694f74 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 179 | 64 | 4 | c09c3eed43d1aa3b7aa8f3021e6f2737840cde16 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 179 | 64 | 4 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_VISp_Trhr_Cpne7|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.29e-04 | 68 | 64 | 3 | cdb805182f7169fbc3bec31adec3a4e088281757 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 180 | 64 | 4 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 180 | 64 | 4 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 180 | 64 | 4 | b51b10781082bc0305ba6a81e978729b329f7771 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 181 | 64 | 4 | 46c428037b6eac605635e20e8cc78bce744b4daa | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 181 | 64 | 4 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 181 | 64 | 4 | 0c3f469bed108994ed696230e3c30343f7a301d3 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 1.39e-04 | 183 | 64 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 1.39e-04 | 183 | 64 | 4 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.39e-04 | 183 | 64 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.42e-04 | 184 | 64 | 4 | e343dd7777a29048e3f12a939f7f782b8b7b4fea | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-04 | 184 | 64 | 4 | 22c18964818fc9c8f18051f836d718937b0d8d12 | |
| ToppCell | facs-Thymus-Flowthrough|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 185 | 64 | 4 | c0587b32f9925052016a06422ddcdc2ad9b7fc93 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 185 | 64 | 4 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.48e-04 | 186 | 64 | 4 | e57a1ee071dab1f4dba944d8032a17d609b3df1a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.51e-04 | 187 | 64 | 4 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.51e-04 | 187 | 64 | 4 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.51e-04 | 187 | 64 | 4 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 187 | 64 | 4 | 7b0168bdaa7c6c6b39878aff6a17f0943189a380 | |
| ToppCell | COVID-19_Severe-B_memory|World / disease group, cell group and cell class | 1.51e-04 | 187 | 64 | 4 | f29c71f2505bb64f3010ada491d422b87a6f7db3 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 64 | 4 | e54e09d34e263d5709c337914809e61e74e20591 | |
| ToppCell | droplet-Fat-Scat-21m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 64 | 4 | 7fc9810ab14354cb512e2b1285562009c10203f5 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.54e-04 | 188 | 64 | 4 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-04 | 189 | 64 | 4 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.57e-04 | 189 | 64 | 4 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 190 | 64 | 4 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.61e-04 | 190 | 64 | 4 | 0db545a4cba7534bad2693e0d565cde7dbc7a586 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 191 | 64 | 4 | f663131a4810584c5854bd64ee7991a237b7707f | |
| ToppCell | PSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.64e-04 | 191 | 64 | 4 | 8f4637e801554e2343b974fe7794f01dd2151418 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 191 | 64 | 4 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 191 | 64 | 4 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.64e-04 | 191 | 64 | 4 | 63d4226a8b59f648bdc9f41e4b2d750dfa342034 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 191 | 64 | 4 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.67e-04 | 192 | 64 | 4 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_mem-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.67e-04 | 192 | 64 | 4 | 185dd150d3345cd29625052a46f3ed89f2a9a8f6 | |
| ToppCell | Hippocampus-Endothelial|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.67e-04 | 192 | 64 | 4 | 36deadab892d3e639a71f33697bb2d3cbbaa5372 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 193 | 64 | 4 | 13282e849b11f48085f0840d112a06e896b32cd7 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_regulatory_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.71e-04 | 193 | 64 | 4 | 28138c35ea82c6b2163f0cae045ca55859347c73 | |
| ToppCell | droplet-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 193 | 64 | 4 | cba070019db30604ebddb610eedf92e48221ac58 | |
| ToppCell | 10x5'-GI_small-bowel|World / Manually curated celltypes from each tissue | 1.71e-04 | 193 | 64 | 4 | cd89dfe53a114078f06343049685883c8e26508f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.71e-04 | 193 | 64 | 4 | 5703a6faaee82cbad5ce73429bdf1b0f47b37ee0 | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.74e-04 | 194 | 64 | 4 | a4523adbbd25c314809eed3414d66a5b323446e5 | |
| ToppCell | CD8+_Memory_T_cell-CV-5|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.74e-04 | 194 | 64 | 4 | 5d644fe6da99b023eee100882ee7b71af4f3814a | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.74e-04 | 194 | 64 | 4 | 84aa5ca0356a06fce8799eb1bfa1c362bab34032 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 1.74e-04 | 194 | 64 | 4 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 194 | 64 | 4 | 3ef9e88e66f2f2ae95dcc834ea605c40c60783fc | |
| ToppCell | BAL-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.74e-04 | 194 | 64 | 4 | 125bf2909cf89133693bc7b865ca08955cf67a2e | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 1.77e-04 | 195 | 64 | 4 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-04 | 195 | 64 | 4 | c16479a10f5ca2e89aea1742dbc5cc4dc9f3ea88 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 1.77e-04 | 195 | 64 | 4 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 1.77e-04 | 195 | 64 | 4 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.77e-04 | 195 | 64 | 4 | 730c613cf6f4d16ca51fd44de1f5a883f615c5c5 | |
| ToppCell | control-Others-CD34+_GATA2+_cells|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.81e-04 | 196 | 64 | 4 | 25994ca143701c72d2f84a3b6d348fcfa1d26a54 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.81e-04 | 196 | 64 | 4 | 4e97010185fa9392da8f69e7b2a7395bf063f8ff | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 1.81e-04 | 196 | 64 | 4 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.81e-04 | 196 | 64 | 4 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.81e-04 | 196 | 64 | 4 | f90e7fe3a7b2fff30d01a25cc500876861c2e4f1 | |
| ToppCell | B_cell_maturation-Memory_B_cell|B_cell_maturation / Lineage and Cell class | 1.81e-04 | 196 | 64 | 4 | 869ed6c83dfe0d874ea2bf2e358f54e5011e80e6 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.84e-04 | 197 | 64 | 4 | 24bcd56df43796af2833c7ce37719c76dd299c19 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.84e-04 | 197 | 64 | 4 | ea7dd7f90be34d8e5936c9c8d35e0918ae64433b | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.84e-04 | 197 | 64 | 4 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic-monocyte-MOP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.84e-04 | 197 | 64 | 4 | 4e68a98bc7e5db7f20e865a0ca21e5a43b3cbb8f | |
| Drug | Tween 20 | 8.31e-06 | 98 | 64 | 5 | CID000443314 | |
| Drug | D4TDP | 1.68e-05 | 18 | 64 | 3 | CID000461279 | |
| Drug | 2-keto-3-deoxy- l-lyxonate | 2.33e-05 | 3 | 64 | 2 | CID000192781 | |
| Drug | acetol phosphate | 2.33e-05 | 3 | 64 | 2 | CID000150865 | |
| Drug | androisoxazole | 2.33e-05 | 3 | 64 | 2 | CID000009676 | |
| Drug | 2-keto-3-bromobutyrate | 2.33e-05 | 3 | 64 | 2 | CID000191968 | |
| Drug | 3-isochromanone | 2.33e-05 | 3 | 64 | 2 | CID000078092 | |
| Drug | 5-deoxy-5-fluoro-L-sorbose | 2.33e-05 | 3 | 64 | 2 | CID000191809 | |
| Drug | D-ribulose-1-p | 2.33e-05 | 3 | 64 | 2 | CID000000615 | |
| Drug | 4-hydroxy-9-fluorenone | 2.33e-05 | 3 | 64 | 2 | CID000016139 | |
| Drug | 4-hydroxy-2-ketopimelate | 2.33e-05 | 3 | 64 | 2 | CID000000553 | |
| Drug | AC1L19F1 | 2.33e-05 | 3 | 64 | 2 | CID000000519 | |
| Drug | Htfp | 2.33e-05 | 3 | 64 | 2 | CID000125055 | |
| Drug | DIDIT | 2.33e-05 | 3 | 64 | 2 | CID000196082 | |
| Drug | diphenylacetylene | 3.14e-05 | 22 | 64 | 3 | CID000010390 | |
| Drug | C06441 | 4.65e-05 | 4 | 64 | 2 | CID000441020 | |
| Drug | formylacetate | 4.65e-05 | 4 | 64 | 2 | CID000075269 | |
| Drug | 3-hydroxy-1-indanone | 4.65e-05 | 4 | 64 | 2 | CID000176448 | |
| Drug | l-123 | 4.65e-05 | 4 | 64 | 2 | CID000093552 | |
| Drug | dihydroxyacetone sulfate | 4.65e-05 | 4 | 64 | 2 | CID000439751 | |
| Drug | AC1L2T2K | 5.26e-05 | 26 | 64 | 3 | CID000128038 | |
| Drug | 1-o-phosphonohex-2-ulose | 7.35e-05 | 29 | 64 | 3 | CID000000481 | |
| Drug | 1,3-dioxan-5-one | 7.74e-05 | 5 | 64 | 2 | CID009793707 | |
| Drug | AC1L4F2K | 7.74e-05 | 5 | 64 | 2 | CID000184526 | |
| Drug | gamma-oxalocitramalate | 7.74e-05 | 5 | 64 | 2 | CID000000130 | |
| Drug | phosphoglycollamide | 7.74e-05 | 5 | 64 | 2 | CID000191768 | |
| Drug | D-erythrulose 1-phosphate | 7.74e-05 | 5 | 64 | 2 | CID000152153 | |
| Drug | 2,3-dihydroxy-p-cumate | 7.74e-05 | 5 | 64 | 2 | CID000029587 | |
| Drug | AC1NX490 | 7.74e-05 | 5 | 64 | 2 | CID005743230 | |
| Drug | hydroxypyruvaldehyde phosphate | 7.74e-05 | 5 | 64 | 2 | CID000193787 | |
| Drug | AC1LA5IX | 9.00e-05 | 31 | 64 | 3 | CID000462147 | |
| Drug | AC1LADSF | 1.07e-04 | 167 | 64 | 5 | CID000486165 | |
| Drug | mycestericin D | 1.16e-04 | 6 | 64 | 2 | CID006439504 | |
| Drug | 2,2-dimethyl-1,3-dioxan-5-one | 1.16e-04 | 6 | 64 | 2 | CID002733141 | |
| Drug | 2-(N-decyl)aminonaphthalene-6-sulfonic acid | 1.16e-04 | 6 | 64 | 2 | CID000189836 | |
| Drug | parapyruvate | 1.16e-04 | 6 | 64 | 2 | CID000440249 | |
| Drug | acetyldithio-CoA | 1.16e-04 | 6 | 64 | 2 | CID003082679 | |
| Drug | 0 Gz | 1.16e-04 | 6 | 64 | 2 | CID000000372 | |
| Drug | chloroacetol phosphate | 1.16e-04 | 6 | 64 | 2 | CID000168137 | |
| Drug | C02783 | 1.16e-04 | 6 | 64 | 2 | CID000439805 | |
| Drug | Methamphetamine | FLNA FLNC PLA1A AHNAK TAS1R1 TRMT1 ADGRF5 DGKH PADI6 MRPL32 HS3ST4 ADCY3 PRDM2 | 1.18e-04 | 1401 | 64 | 13 | ctd:D008694 |
| Drug | 2'-deoxyuridine-5'-monophosphate | 1.43e-04 | 94 | 64 | 4 | CID000000688 | |
| Drug | 5-deoxy-D-xylulose-1-phosphate | 1.62e-04 | 7 | 64 | 2 | CID000192931 | |
| Drug | Z-Glu-Tyr | 1.62e-04 | 7 | 64 | 2 | CID000096820 | |
| Drug | acenaphthenone | 1.62e-04 | 7 | 64 | 2 | CID000075229 | |
| Drug | C0447 | 1.62e-04 | 7 | 64 | 2 | CID000128786 | |
| Drug | AC1L1X9L | 1.62e-04 | 7 | 64 | 2 | CID000037209 | |
| Drug | DAPpNP | 1.62e-04 | 7 | 64 | 2 | CID005492375 | |
| Drug | 3-hydroxy-4-oxobutyl-1-phosphonate | 2.15e-04 | 8 | 64 | 2 | CID003016813 | |
| Drug | L-rhamnulose-1-phosphate | 2.15e-04 | 8 | 64 | 2 | CID000439413 | |
| Drug | amorphin | 2.15e-04 | 8 | 64 | 2 | CID000122792 | |
| Drug | Bezafibrate [41859-67-0]; Up 200; 11uM; PC3; HT_HG-U133A | 2.32e-04 | 197 | 64 | 5 | 6653_UP | |
| Drug | Nitrendipine [39562-70-4]; Down 200; 11uM; PC3; HT_HG-U133A | 2.38e-04 | 198 | 64 | 5 | 6304_DN | |
| Drug | Monensin | 2.76e-04 | 9 | 64 | 2 | ctd:D008985 | |
| Drug | 2-oxopentenoate | 2.76e-04 | 9 | 64 | 2 | CID000000976 | |
| Drug | Glafenine | FLNA ABCA1 PLA1A EIF2S3 RPS7 NFKBIZ OLA1 NME1 TRIM6 NME2 ALDOA DDC | 2.86e-04 | 1327 | 64 | 12 | ctd:D005897 |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 1.30e-05 | 3 | 62 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 1.30e-05 | 3 | 62 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 2.56e-05 | 277 | 62 | 6 | C0009404 | |
| Disease | teratoma (is_implicated_in) | 4.33e-05 | 5 | 62 | 2 | DOID:3307 (is_implicated_in) | |
| Disease | nucleoside diphosphate kinase B measurement | 9.06e-05 | 7 | 62 | 2 | EFO_0020615 | |
| Disease | pimelic acid measurement, 3-methyladipic acid measurement | 3.89e-04 | 14 | 62 | 2 | EFO_0010449, EFO_0010524 | |
| Disease | Depression, Bipolar | 6.23e-04 | 79 | 62 | 3 | C0005587 | |
| Disease | Colorectal Carcinoma | 6.62e-04 | 702 | 62 | 7 | C0009402 | |
| Disease | sex interaction measurement, body mass index, age at assessment | 1.07e-03 | 23 | 62 | 2 | EFO_0004340, EFO_0008007, EFO_0008343 | |
| Disease | white matter microstructure measurement | 1.37e-03 | 390 | 62 | 5 | EFO_0005674 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGLRGGRVVELKKIV | 221 | Q9NUB1 | |
| QEGRPVQVIGALIGK | 61 | Q7L5N1 | |
| KGIVVGIKLDQGGAP | 101 | P05062 | |
| KGGVVGIKVDKGVVP | 101 | P04075 | |
| IKVRVIKVKGGRGDI | 356 | Q8IVW4 | |
| EIILKVPVEIVGQGK | 146 | Q9UK96 | |
| ALLRGVPEKEVGKVG | 2011 | O95477 | |
| GVDVTLPRVEGKVKV | 586 | Q09666 | |
| GGGVKLVVKPRRQSE | 2386 | Q8TDJ6 | |
| ERAGLIGGVKLKAIP | 196 | P20711 | |
| LVQRGDIIKVVPGGK | 841 | Q04656 | |
| LEDGKLIVVGVGKPA | 2646 | Q6ZS30 | |
| GLGRKKQGIVTPIEA | 876 | P98175 | |
| GPIIDKLEKVAVRGG | 161 | Q9NTK5 | |
| IKPDGVQRGLVGEII | 11 | P22392 | |
| KVQGKEYPLGRVLIG | 426 | Q6TGC4 | |
| QLPQAIIIGVKKGGT | 136 | Q9Y662 | |
| GPVGEQIRRILKGKS | 696 | Q9BYH8 | |
| GEKGVPKTGLLIIVL | 196 | A2A368 | |
| INKVGKELGIIPTII | 201 | Q8NDH3 | |
| EQKDIPGGVLKIRDG | 1516 | Q14999 | |
| PVVGVRKKVRGPEQI | 396 | Q9H8E8 | |
| GRGLQPKGVRVKEVA | 481 | Q14315 | |
| VVLVGPVGVGLNELK | 371 | Q5T2T1 | |
| GLVVGPKGATIKRIQ | 286 | Q86XN8 | |
| QLPQAIIIGVKKGGT | 151 | Q9Y663 | |
| PKVGHVKRILQGIKE | 1196 | Q86XP1 | |
| VIKKRVVVEPVGPVG | 391 | Q9BZE1 | |
| LLGPEVVVGGERTKI | 406 | Q8IZE3 | |
| LLEGPVRVKEGREGK | 411 | Q3KR16 | |
| TIKPKEKIGIVGRTG | 1216 | O15440 | |
| KLRGKVDPVLIVGSG | 296 | Q9Y236 | |
| IQRKKVAVIGGGLVG | 6 | O15229 | |
| VGRGLQPKGVRVKET | 486 | P21333 | |
| NPGIVRKKKIAIGVI | 321 | Q8TF40 | |
| VRRGPIFVKGKGELL | 1101 | O60266 | |
| INIREDPKEGIKIVG | 161 | O95239 | |
| INIREDPKEGIKIVG | 161 | Q2VIQ3 | |
| GVRKGIPKVVVVFID | 261 | O43405 | |
| KLPQALIIGVKKGGT | 196 | Q9Y661 | |
| IPKGVRRKGGLEEPQ | 511 | Q13029 | |
| VVGLVVGPKGATIKR | 171 | Q6ZN04 | |
| RGVKVLKQELGGLGI | 111 | Q13884 | |
| QLGAKGIQIKVPGEK | 96 | Q9NXH9 | |
| EIRRQIGKQEGGPFK | 136 | Q9BYC8 | |
| IEVGGGRKAIIIFVP | 51 | P62081 | |
| VGRIVIGLFGKVVPK | 51 | P45877 | |
| IKPDGVQRGLVGEII | 11 | P15531 | |
| PQVLIKGGRIRKQVI | 1256 | P25391 | |
| RVVGLVVGPKGATIK | 336 | Q5U5Q3 | |
| VKKRALIAGGGAPEI | 416 | P50991 | |
| GGRIIVEVDGKVAKI | 21 | Q9P2P6 | |
| DPVIGVGEPGKVIQK | 671 | Q8IZF2 | |
| PKLGQIGRAKRVVIE | 46 | Q96S95 | |
| RRGVEIEEGGVKVKL | 76 | Q8WYJ6 | |
| RIGLVEQGGVKIEPL | 306 | Q53H76 | |
| VLGVAIQKRAVPGLK | 321 | Q7RTX1 | |
| GLVVGPKGATIKRIQ | 236 | A1L020 | |
| EQTKERGGVAIKIPI | 311 | O94759 | |
| KIILKIGAVVGGVLL | 191 | Q3KNW5 | |
| GIRVLKKGPQDGVAR | 806 | Q96AE7 | |
| LEEKKQGGPAIGARI | 1021 | Q9ULL1 | |
| LREVVLGPGKQLKAV | 81 | Q9C030 | |
| GVLKVGQEIEVRPGI | 286 | P41091 |